Education
About Us
Working with TipRanks
Follow Us
PAVmed Inc (PAVM)
NASDAQ:PAVM
Total Valuation
PAVmed has a market cap or net worth of $11.24M. The enterprise value is $6.55B.
Market Cap$11.24M
Enterprise Value$6.55B
Share Statistics
PAVmed has 17,294,619 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding17,294,619
Owned by Insiders5.78%
Owned by Institutions4.38%
Financial Efficiency
PAVmed’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is 150.57%.
Return on Equity (ROE)-0.02
Return on Assets (ROA)1.30
Return on Invested Capital (ROIC)150.57%
Return on Capital Employed (ROCE)1.26
Revenue Per Employee76.79K
Profits Per Employee728.90K
Employee Count39
Asset Turnover0.10
Inventory Turnover18.20
Valuation Ratios
The current PE Ratio of PAVmed is 0.15. PAVmed’s PEG ratio is <0.01.
PE Ratio0.15
PS Ratio0.00
PB Ratio0.20
Price to Fair Value>-0.01
Price to FCF>-0.01
Price to Operating Cash Flow-5.62
PEG Ratio<0.01
Income Statement
In the last 12 months, PAVmed had revenue of 3.00M and earned 39.79M in profits. Earnings per share was 3.30.
Revenue3.00M
Gross Profit-1.84B
Operating Income-44.49B
Pretax Income28.43B
Net Income39.79M
EBITDA-44.49B
Earnings Per Share (EPS)3.30
Cash Flow
In the last 12 months, operating cash flow was -1.60B and capital expenditures -13.00K, giving a free cash flow of -1.60B billion.
Operating Cash Flow-1.60B
Free Cash Flow-1.60B
Free Cash Flow per Share-92.60
Dividends & Yields
PAVmed pays an annual dividend of $0.551, resulting in a dividend yield of ―
Dividend Per Share$0.551
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.83
52-Week Price Change-58.60%
50-Day Moving Average0.71
200-Day Moving Average0.86
Relative Strength Index (RSI)43.95
Average Volume (3m)151.73K
Important Dates
PAVmed upcoming earnings date is Aug 19, 2025, TBA Not Confirmed.
Last Earnings DateMay 15, 2025
Next Earnings DateAug 19, 2025
Ex-Dividend DateJan 11, 2024
Financial Position
PAVmed as a current ratio of 0.06, with Debt / Equity ratio of 20.53%
Current Ratio0.06
Quick Ratio0.06
Debt to Market Cap4.79
Net Debt to EBITDA>-0.01
Interest Coverage Ratio-988.60K
Taxes
In the past 12 months, PAVmed has paid -3.54B in taxes.
Income Tax-3.54B
Effective Tax Rate-0.12
Enterprise Valuation
PAVmed EV to EBITDA ratio is >-0.01, with an EV/FCF ratio of -1.09.
EV to Sales12.27
EV to EBITDA>-0.01
EV to Free Cash Flow-1.09
EV to Operating Cash Flow-1.10
Balance Sheet
PAVmed has $2.70B in cash and marketable securities with $9.24B in debt, giving a net cash position of $6.54B billion.
Cash & Marketable Securities$2.70B
Total Debt$9.24B
Net Cash$6.54B
Net Cash Per Share$378.04
Tangible Book Value Per Share-$0.73
Margins
Gross margin is -295.28%, with operating margin of -1485375.63%, and net profit margin of 1328.58%.
Gross Margin-295.28%
Operating Margin-1485375.63%
Pretax Margin949148.58%
Net Profit Margin1328.58%
EBITDA Margin-1485375.63%
EBIT Margin950.65%
Analyst Forecast
The average price target for PAVmed is $9.17, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$9.17
Price Target Upside1310.77% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast-33.92%
EPS Growth Forecast―